Patents by Inventor Winfried Ness

Winfried Ness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRIALKYL SULFONIUM SALTS
    Publication number: 20240032533
    Abstract: The invention relates to trialkyl sulfonium salts, compositions comprising the trialkyl sulfonium salts, agricultural compositions comprising such compositions, to the use of the trialkyl sulfonium salts and of the compositions as pesticide, preferably as fungicide, and to methods for controlling or combating pests and/or improving plant health by means of the trialkyl sulfonium salts and the compositions.
    Type: Application
    Filed: October 1, 2021
    Publication date: February 1, 2024
    Applicants: HELM AG, UNIVERSITY OF EXETER
    Inventors: Winfried NESS, Henrique RAMINHOS, Joerg STROOT, Johann Christian NIENDORF, Gero STEINBERG, Sarah GURR
  • TRIALKYL SULFONIUM CHLORIDES AS FUNGICIDES
    Publication number: 20230413811
    Abstract: The invention relates to a trialkyl sulfonium chloride, compositions comprising the trialkyl sulfonium chloride, agricultural compositions comprising such compositions and trialkyl sulfonium chloride, respectively, to the use of the trialkyl sulfonium chloride and of the compositions as a pesticide, preferably as a fungicide, and to methods for controlling or combating pests and/or improving plant health by means of the trialkyl sulfonium chloride and compositions.
    Type: Application
    Filed: October 1, 2021
    Publication date: December 28, 2023
    Applicants: HELM AG, UNIVERSITY OF EXETER
    Inventors: Winfried NESS, Henrique RAMINHOS, Joerg STROOT, Johann Christian NIENDORF, Gero STEINBERG, Sarah GURR
  • Stereoselective method for the production of (R)-Dimepranol
    Patent number: 7799952
    Abstract: The present invention relates to processes for preparing a compound of the general formula (Ia) wherein X is a halogen atom, or a pharmaceutically acceptable salt thereof, wherein a compound of the formula (II) wherein X is as defined above and Y and Z independently represent a leaving group each, is reacted with an optically active amino alcohol to form a first mixture of diastereomers.
    Type: Grant
    Filed: February 10, 2009
    Date of Patent: September 21, 2010
    Assignee: ratiopharm GmbH
    Inventors: Jiri Stohandl, Jaroslav Frantisek, Winfried Ness
  • Stereoselective Method for the Production of (R)-Dimepranol
    Publication number: 20090149677
    Abstract: The present invention relates to processes for preparing a compound of the general formula (Ia) wherein X is a halogen atom, or a pharmaceutically acceptable salt thereof, wherein a compound of the formula (II) wherein X is as defined above and Y and Z independently represent a leaving group each, is reacted with an optically active amino alcohol to form a first mixture of diastereomers.
    Type: Application
    Filed: February 10, 2009
    Publication date: June 11, 2009
    Applicant: ratiopharm GmbH
    Inventors: Jiri Stohandl, Jaroslav Frantisek, Winfried Ness
  • Stereoselective method for the production of Clopidogrel
    Patent number: 7507827
    Abstract: The present invention relates to processes for preparing a compound of the general formula (Ia) wherein X is a halogen atom, or a pharmaceutically acceptable salt thereof, wherein a compound of the formula (II) wherein X is as defined above and Y and Z independently represent a leaving group each, is reacted with an optically active amino alcohol to form a first mixture of diastereomers.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: March 24, 2009
    Assignee: ratiopharm GmbH
    Inventors: Jiri Stohandl, Jaroslav Frantisek, Winfried Ness
  • Stereoselective Method for the Production of Clopidogrel
    Publication number: 20070219166
    Abstract: The present invention relates to processes for preparing a compound of the general formula (Ia) wherein X is a halogen atom, or a pharmaceutically acceptable salt thereof, wherein a compound of the formula (II) wherein X is as defined above and Y and Z independently represent a leaving group each, is reacted with an optically active amino alcohol to form a first mixture of diastereomers.
    Type: Application
    Filed: December 3, 2004
    Publication date: September 20, 2007
    Inventors: Jiri Stohandl, Jaroslav Frantisek, Winfried Ness